NCT01234311_2B | R Documentation |
Kaplan-Meier digitized data from NCT01234311, figure 2B (PMID 27298414). A reported sample size of 1,245 for a primary endpoint of rPFS in prostate cancer.
NCT01234311_2B
A data frame of 1,158 observations and 3 variables:
time | event time (in months) | |
event | OS event indicator (0 : no event, 1 : event) |
|
arm | treatment arms (placebo, tasq) | |
Sternberg C, Armstrong A, Pili R, et al. Randomized, Double-Blind, Placebo-Controlled Phase III Study of Tasquinimod in Men With Metastatic Castration-Resistant Prostate Cancer. J Clin Oncol 2016; 34: 2636–43.
summary(NCT01234311_2B)
kmplot(NCT01234311_2B)
Add the following code to your website.
For more information on customizing the embed code, read Embedding Snippets.